100 related articles for article (PubMed ID: 21875379)
1. An experimental protocol for the fractionation and 2DE separation of HeLa and A-253 cell lysates suitable for the identification of the individual antigenic proteome in Sjögren's syndrome.
Nginamau ES; Maehle BO; Jonsson R
Autoimmunity; 2011 Dec; 44(8):652-63. PubMed ID: 21875379
[TBL] [Abstract][Full Text] [Related]
2. Detection of anti-type 3 muscarinic acetylcholine receptor autoantibodies in the sera of Sjögren's syndrome patients by use of a transfected cell line assay.
Gao J; Cha S; Jonsson R; Opalko J; Peck AB
Arthritis Rheum; 2004 Aug; 50(8):2615-21. PubMed ID: 15334476
[TBL] [Abstract][Full Text] [Related]
3. The role of M3 muscarinic acetylcholine receptor reactive T cells in Sjögren's syndrome: a critical review.
Sumida T; Tsuboi H; Iizuka M; Hirota T; Asashima H; Matsumoto I
J Autoimmun; 2014 Jun; 51():44-50. PubMed ID: 24397962
[TBL] [Abstract][Full Text] [Related]
4. Functional role of M3 muscarinic acetylcholine receptor (M3R) reactive T cells and anti-M3R autoantibodies in patients with Sjögren's syndrome.
Sumida T; Tsuboi H; Iizuka M; Nakamura Y; Matsumoto I
Autoimmun Rev; 2010 Jul; 9(9):615-7. PubMed ID: 20462524
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome.
Waterman SA; Gordon TP; Rischmueller M
Arthritis Rheum; 2000 Jul; 43(7):1647-54. PubMed ID: 10902771
[TBL] [Abstract][Full Text] [Related]
6. Identification of tear lipocalin as a novel autoantigen target in Sjögren's syndrome.
Navone R; Lunardi C; Gerli R; Tinazzi E; Peterlana D; Bason C; Corrocher R; Puccetti A
J Autoimmun; 2005 Nov; 25(3):229-34. PubMed ID: 16249071
[TBL] [Abstract][Full Text] [Related]
7. Fcgamma receptors mediate internalization of anti-Ro and anti-La autoantibodies from Sjögren's syndrome and apoptosis in human salivary gland cell line A-253.
Lisi S; Sisto M; Soleti R; Saponaro C; Scagliusi P; D'Amore M; Saccia M; Maffione AB; Mitolo V
J Oral Pathol Med; 2007 Oct; 36(9):511-23. PubMed ID: 17850433
[TBL] [Abstract][Full Text] [Related]
8. Anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjögren's syndrome.
Sumida T; Tsuboi H; Iizuka M; Asashima H; Matsumoto I
Mod Rheumatol; 2013 Sep; 23(5):841-5. PubMed ID: 23135882
[TBL] [Abstract][Full Text] [Related]
9. Putative anti-muscarinic antibodies cannot be detected in patients with primary Sjogren's syndrome using conventional immunological approaches.
Dawson LJ; Allison HE; Stanbury J; Fitzgerald D; Smith PM
Rheumatology (Oxford); 2004 Dec; 43(12):1488-95. PubMed ID: 15353609
[TBL] [Abstract][Full Text] [Related]
10. Pathogenic role of anti-M3 muscarinic acetylcholine receptor immune response in Sjögren's syndrome.
Sumida T; Iizuka M; Asashima H; Tsuboi H; Matsumoto I
Presse Med; 2012 Sep; 41(9 Pt 2):e461-6. PubMed ID: 22884125
[TBL] [Abstract][Full Text] [Related]
11. Antimuscarinic antibodies in primary Sjögren's syndrome reversibly inhibit the mechanism of fluid secretion by human submandibular salivary acinar cells.
Dawson LJ; Stanbury J; Venn N; Hasdimir B; Rogers SN; Smith PM
Arthritis Rheum; 2006 Apr; 54(4):1165-73. PubMed ID: 16572451
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies against a 72-kDa ductal cell membrane glycoprotein in a patient affected by Sjögren's syndrome and gastric MALT lymphoma.
Folli F; Perego L; Ponzoni M; Girardi AM; Bosi E; Ferreri AJ; Bellone M; Sabbadini MG; Vicari AM; Trusolino L
Ann Hematol; 2002 Oct; 81(10):597-602. PubMed ID: 12424543
[TBL] [Abstract][Full Text] [Related]
13. Analysis of parotid glands of primary Sjögren's syndrome patients using proteomic technology reveals altered autoantigen composition and novel antigenic targets.
Stea EA; Routsias JG; Samiotaki M; Panayotou G; Papalambros E; Moutsopoulos HM; Tzioufas AG
Clin Exp Immunol; 2007 Jan; 147(1):81-9. PubMed ID: 17177966
[TBL] [Abstract][Full Text] [Related]
14. Evidence that anti-muscarinic antibodies in Sjögren's syndrome recognise both M3R and M1R.
Schegg V; Vogel M; Didichenko S; Stadler MB; Beleznay Z; Gadola S; Sengupta C; Stadler BM; Miescher SM
Biologicals; 2008 Jul; 36(4):213-22. PubMed ID: 18249005
[TBL] [Abstract][Full Text] [Related]
15. Centromere protein C is a target of autoantibodies in Sjögren's syndrome and is uniformly associated with antibodies to Ro and La.
Pillemer SR; Casciola-Rosen L; Baum BJ; Rosen A; Gelber AC
J Rheumatol; 2004 Jun; 31(6):1121-5. PubMed ID: 15170924
[TBL] [Abstract][Full Text] [Related]
16. Common T cell receptor clonotype in lacrimal glands and labial salivary glands from patients with Sjögren's syndrome.
Matsumoto I; Tsubota K; Satake Y; Kita Y; Matsumura R; Murata H; Namekawa T; Nishioka K; Iwamoto I; Saitoh Y; Sumida T
J Clin Invest; 1996 Apr; 97(8):1969-77. PubMed ID: 8621782
[TBL] [Abstract][Full Text] [Related]
17. Muscarinic acetylcholine receptor antibodies as a new marker of dry eye Sjögren syndrome.
Bacman S; Berra A; Sterin-Borda L; Borda E
Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):321-7. PubMed ID: 11157861
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of the RNA and protein components recognized by anti-La(SS-B) autoantibodies.
McNeilage LJ; Whittingham S; Jack I; MacKay IR
Clin Exp Immunol; 1985 Dec; 62(3):685-95. PubMed ID: 2417765
[TBL] [Abstract][Full Text] [Related]
19. Functional epitope of muscarinic type 3 receptor which interacts with autoantibodies from Sjogren's syndrome patients.
Koo NY; Li J; Hwang SM; Choi SY; Lee SJ; Oh SB; Kim JS; Lee EB; Song YW; Park K
Rheumatology (Oxford); 2008 Jun; 47(6):828-33. PubMed ID: 18400835
[TBL] [Abstract][Full Text] [Related]
20. Pathogenic role of immune response to M3 muscarinic acetylcholine receptor in Sjögren's syndrome-like sialoadenitis.
Iizuka M; Wakamatsu E; Tsuboi H; Nakamura Y; Hayashi T; Matsui M; Goto D; Ito S; Matsumoto I; Sumida T
J Autoimmun; 2010 Dec; 35(4):383-9. PubMed ID: 20864316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]